Peter Hirth
Adviser and Angel investor at EIR Ventures
About
Biotechnology entrepreneur with over 30 years in pharmaceutical discovery and development. Co-founder and CEO of Plexxikon (developed Zelboraf for melanoma) and co-founder of Sugen (advanced kinase inhibitors in oncology including Sutent). Also served as VP of Research at Boehringer Mannheim and holds board positions at multiple biotech companies.
Colleagues at EIR Ventures
Amanda Hayward
Founding Partner at EIR Ventures
Carani Sanjeevi
Advisor at EIR Ventures
Harald Ekman
Co-founder and CFO at EIR Ventures
Lovisa Backemar
Partner at EIR Ventures
Magnus Persson
Founding Partner at EIR Ventures
Stephan Christgau
Founding Partner at EIR Ventures
Thomas Perlmann
Advisor at EIR Ventures
Tobias Horneman-Thielcke
Partner at EIR Ventures